Knowledge, Attitudes, and Experiences of HIV Pre-Exposure Prophylaxis (PrEP) Trial Participants in Botswana

Recent clinical trials have shown that a daily dose of oral TDF/FTC pre-exposure prophylaxis (PrEP) is effective in reducing human immunodeficiency (HIV) risk. Understanding trial participants’ perspectives about retention and PrEP adherence is critical to inform future PrEP trials and the scale-up...

Descripción completa

Detalles Bibliográficos
Autores principales: Toledo, Lauren, McLellan-Lemal, Eleanor, Henderson, Faith L., Kebaabetswe, Poloko M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708891/
https://www.ncbi.nlm.nih.gov/pubmed/26767149
http://dx.doi.org/10.4236/wja.2015.51002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708891/
https://www.ncbi.nlm.nih.gov/pubmed/26767149
http://dx.doi.org/10.4236/wja.2015.51002

Ejemplares similares